A role for NADPH oxidase in antigen presentation

Frontiers in Immunology

Volumn 4, Issue SEP, 2013, Pages

  Gardiner, Gail J ^a   Deffit, Sarah N ^a   McLetchie, Shawna ^a   Pérez, Liliana ^a   Walline, Crystal C ^a   Blum, Janice S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen presentation; Autoimmunity; B lymphocytes; Chronic granulomatous disease; NADPH oxidase

Indexed keywords

CD4 ANTIGEN; GUANOSINE TRIPHOSPHATASE; HLA DM ANTIGEN; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE (CYTOCHROME); MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; AUTOIMMUNITY; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC GRANULOMATOUS DISEASE; DENDRITIC CELL; DNA POLYMORPHISM; GRANULOMATOUS INFLAMMATION; HISTOCOMPATIBILITY COMPLEX; HUMAN; IMMUNE RESPONSE; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; RECURRENT INFECTION; SHORT SURVEY;

EID: 84886059315     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00295     Document Type: Short Survey

References (61)

1. Bokoch GM, Knaus UG. NADPH oxidases: not just for leukocytes anymore! Trends Biochem Sci (2003) 28:502-8. doi: 10.1016/S0968-0004(03)00194-4.
2. Nauseef WM. Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol (2004) 122:277-91. doi:10.1007/s00418-004-0679-8.
3. Groemping Y, Rittinger K. Activation and assembly of the NADPH oxidase: a structural perspective. Biochem J (2005) 386:401-16. doi:10.1042/BJ20041835.
4. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 79:155-69. doi:10.1097/00005792-200005000-00003.
5. Romera Modamio G, Martin Mateos MA, Gonzalez Ensenat MA, Pastor Gomez MA. Chronic granulomatous disease: a case study of a symptomatic carrier. J Investig Allergol Clin Immunol (1997) 7:57-61.
6. Lewis EM, Singla M, Sergeant S, Koty PP, Mcphail LC. X-linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation. Clin Immunol (2008) 129:372-80. doi:10.1016/j.clim.2008.07.022.
7. van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS One (2009) 4:e5234. doi:10.1371/journal.pone.0005234.
8. Williams DA, Tao W, Yang F, Kim C, Gu Y, Mansfield P, et al. Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood (2000) 96:1646-54.
9. Matute JD, Arias AA, Wright NA, Wrobel I, Waterhouse CC, Li XJ, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood (2009) 114:3309-15. doi:10.1182/blood-2009-07-231498.
10. Segal BH, Veys P, Malech H, Cowan MJ. Chronic granulomatous disease: lessons from a rare disorder. Biol Blood Marrow Transplant (2011) 17:S123-31. doi:10.1016/j.bbmt.2010.09.008.
11. Segal BH, Grimm MJ, Khan AN, Han W, Blackwell TS. Regulation of innate immunity by NADPH oxidase. Free Radic Biol Med (2012) 53:72-80. doi:10.1016/j.freeradbiomed.2012.04.022.
12. Manzi S, Urbach AH, Mccune AB, Altman HA, Kaplan SS, Medsger TA Jr, et al. Systemic lupus erythematosus in a boy with chronic granulomatous disease: case report and review of the literature. Arthritis Rheum (1991) 34:101-5. doi:10.1002/art.1780340116.
13. Martin-Villa JM, Corell A, Ramos-Amador JT, Ruiz-Contreras J, Arnaiz-Villena A. Higher incidence of autoantibodies in X-linked chronic granulomatous disease carriers: random X-chromosome inactivation may be related to autoimmunity. Autoimmunity (1999) 31:261-4. doi:10.3109/08916939908994071.
14. Cale CM, Morton L, Goldblatt D. Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology. Clin Exp Immunol (2007) 148:79-84. doi:10.1111/j.1365-2249.2007.03321.x.
15. De Ravin SS, Naumann N, Cowen EW, Friend J, Hilligoss D, Marquesen M, et al. Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol (2008) 122:1097-103. doi:10.1016/j.jaci.2008.07.050.
16. Lee BW, Yap HK. Polyarthritis resembling juvenile rheumatoid arthritis in a girl with chronic granulomatous disease. Arthritis Rheum (1994) 37:773-6. doi:10.1002/art.1780370524.
17. De Ravin SS, Naumann N, Robinson MR, Barron KS, Kleiner DE, Ulrick J, et al. Sarcoidosis in chronic granulomatous disease. Pediatrics (2006) 117:e590-5. doi:10.1542/peds.2005-1349.
18. Jacob CO, Eisenstein M, Dinauer MC, Ming W, Liu Q, John S, et al. Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci U S A (2012) 109:E59-67. doi:10.1073/pnas.1113251108.
19. Olsson LM, Lindqvist AK, Kallberg H, Padyukov L, Burkhardt H, Alfredsson L, et al. A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity. Arthritis Res Ther (2007) 9:R98. doi:10.1186/ar2299.
20. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet (2007) 39:596-604. doi:10.1038/ng2032.
21. Roberts RL, Hollis-Moffatt JE, Gearry RB, Kennedy MA, Barclay ML, Merriman TR. Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort. Genes Immun (2008) 9:561-5. doi:10.1038/gene.2008.49.
22. George-Chandy A, Nordstrom I, Nygren E, Jonsson IM, Postigo J, Collins LV, et al. Th17 development and autoimmune arthritis in the absence of reactive oxygen species. Eur J Immunol (2008) 38:1118-26. doi:10.1002/eji.200737348.
23. Jendrysik MA, Vasilevsky S, Yi L, Wood A, Zhu N, Zhao Y, et al. NADPH oxidase-2 derived ROS dictates murine DC cytokine-mediated cell fate decisions during CD4 T helper-cell commitment. PLoS One (2011) 6:e28198. doi:10.1371/journal.pone.0028198.
24. Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y, et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity (2006) 25:153-62. doi:10.1016/j.immuni.2006.04.017.
25. John B, Harris TH, Tait ED, Wilson EH, Gregg B, Ng LG, et al. Dynamic Imaging of CD8(+) T cells and dendritic cells during infection with Toxoplasma gondii. PLoS Pathog (2009) 5:e1000505. doi:10.1371/journal.ppat.1000505.
26. Ballesteros-Tato A, Leon B, Lund FE, Randall TD. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat Immunol (2010) 11:216-24. doi:10.1038/ni.1838.
27. Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 184:923-30. doi:10.1084/jem.184.3.923.
28. Hernandez J, Aung S, Redmond WL, Sherman LA. Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J Exp Med (2001) 194:707-17. doi:10.1084/jem.194.6.707.
29. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med (2002) 196:1627-38. doi:10.1084/jem.20021598.
30. Luckashenak N, Schroeder S, Endt K, Schmidt D, Mahnke K, Bachmann MF, et al. Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. Immunity (2008) 28:521-32. doi:10.1016/j.immuni.2008.02.018.
31. Ackerman AL, Giodini A, Cresswell P. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity (2006) 25:607-17. doi:10.1016/j.immuni.2006.08.017.
32. Imai T, Kato Y, Kajiwara C, Mizukami S, Ishige I, Ichiyanagi T, et al. Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells. Proc Natl Acad Sci U S A (2011) 108:16363-8. doi:10.1073/pnas.1108372108.
33. Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, Van Endert P, Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature (2003) 425:397-402. doi:10.1038/nature01911.
34. Shen L, Sigal LJ, Boes M, Rock KL. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity (2004) 21:155-65. doi:10.1016/j.immuni.2004.07.004.
35. Bertholet S, Goldszmid R, Morrot A, Debrabant A, Afrin F, Collazo-Custodio C, et al. Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo. J Immunol (2006) 177:3525-33.
36. Savina A, Jancic C, Hugues S, Guermonprez P, Vargas P, Moura IC, et al. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell (2006) 126:205-18. doi:10.1016/j.cell.2006.05.035.
37. Mantegazza AR, Savina A, Vermeulen M, Perez L, Geffner J, Hermine O, et al. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood (2008) 112:4712-22. doi:10.1182/blood-2008-01-134791.
38. Savina A, Peres A, Cebrian I, Carmo N, Moita C, Hacohen N, et al. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells. Immunity (2009) 30:544-55. doi:10.1016/j.immuni.2009.01.013.
39. Jancic C, Savina A, Wasmeier C, Tolmachova T, El-Benna J, Dang PM, et al. Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nat Cell Biol (2007) 9:367-78. doi:10.1038/ncb1552.
40. Rybicka JM, Balce DR, Chaudhuri S, Allan ER, Yates RM. Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner. EMBO J (2012) 31:932-44. doi:10.1038/emboj.2011.440.
41. Crotzer VL, Matute JD, Arias AA, Zhao H, Quilliam LA, Dinauer MC, et al. Cutting edge: NADPH oxidase modulates MHC class II antigen presentation by B cells. J Immunol (2012) 189:3800-4. doi:10.4049/jimmunol.1103080.
42. Roche PA, Marks MS, Cresswell P. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature (1991) 354:392-4. doi:10.1038/354392a0.
43. Bakke O, Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell (1990) 63:707-16. doi:10.1016/0092-8674(90)90137-4.
44. Blum JS, Cresswell P. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci U S A (1988) 85:3975-9. doi:10.1073/pnas.85.11.3975.
45. Thomas LJ, Nguyen QV, Elliott WL, Humphreys RE. Proteolytic cleavage of Ii to p25. J Immunol (1988) 140:2670-4.
46. Morkowski S, Goldrath AW, Eastman S, Ramachandra L, Freed DC, Whiteley P, et al. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates. J Exp Med (1995) 182:1403-13. doi:10.1084/jem.182.5.1403.
47. Mellins E, Smith L, Arp B, Cotner T, Celis E, Pious D. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature (1990) 343:71-4. doi:10.1038/343071a0.
48. Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell (1995) 82:155-65. doi:10.1016/0092-8674(95)90061-6.
49. Hsieh CS, Deroos P, Honey K, Beers C, Rudensky AY. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation. J Immunol (2002) 168:2618-25.
50. Maric M, Arunachalam B, Phan UT, Dong C, Garrett WS, Cannon KS, et al. Defective antigen processing in GILT-free mice. Science (2001) 294:1361-5. doi:10.1126/science.1065500.
51. Li P, Haque MA, Blum JS. Role of disulfide bonds in regulating antigen processing and epitope selection. J Immunol (2002) 169:2444-50.
52. Lewis CJ, Cobb BA. Carbohydrate oxidation acidifies endosomes, regulating antigen processing and TLR9 signaling. J Immunol (2010) 184:3789-800. doi:10.4049/jimmunol.0903168.
53. Heijnen CJ, Van Der Meer JW, Zegers BJ. Altered antigen-presentation in the induction of the in-vitro antigen-specific T helper cell function in patients with chronic granulomatous disease. Clin Exp Immunol (1986) 66:111-7.
54. Barbey C, Tiercy JM, Fairweather N, Niemann H, Seger R, Corradin G. Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impaired. Clin Exp Immunol (1994) 95:227-31. doi:10.1111/j.1365-2249.1994.tb06515.x.
55. Kobayashi S, Imajoh-Ohmi S, Kuribayashi F, Nunoi H, Nakamura M, Kanegasaki S. Characterization of the superoxide-generating system in human peripheral lymphocytes and lymphoid cell lines. J Biochem (1995) 117:758-65.
56. Bleesing JJ, Souto-Carneiro MM, Savage WJ, Brown MR, Martinez C, Yavuz S, et al. Patients with chronic granulomatous disease have a reduced peripheral blood memory B cell compartment. J Immunol (2006) 176:7096-103.
57. Moir S, De Ravin SS, Santich BH, Kim JY, Posada JG, Ho J, et al. Humans with chronic granulomatous disease maintain humoral immunologic memory despite low frequencies of circulating memory B cells. Blood (2012) 120:4850-8. doi:10.1182/blood-2012-05-430959.
58. Hasui M, Hattori K, Taniuchi S, Kohdera U, Nishikawa A, Kinoshita Y, et al. Decreased CD4+CD29+ (memory T) cells in patients with chronic granulomatous disease. J Infect Dis (1993) 167:983-5. doi:10.1093/infdis/167.4.983.
59. Horvath R, Rozkova D, Lastovicka J, Polouckova A, Sedlacek P, Sediva A, et al. Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease. Clin Exp Immunol (2011) 166:26-33. doi:10.1111/j.1365-2249.2011.04449.x.
60. Montes-Berrueta D, Ramirez L, Salmen S, Berrueta L. Fas and FasL expression in leukocytes from chronic granulomatous disease patients. Invest Clin (2012) 53:157-67.
61. Crotzer VL, Glosson N, Zhou D, Nishino I, Blum JS. LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens. Immunology (2010) 131:318-30. doi:10.1111/j.1365-2567.2010.03309.x.